E2F8 p.Arg372Gln
c.1115G>A · rs375962806 · VCV2330137
Computational evidence
| Protein change | ||
| AlphaMissense | 0.06 | likely benign |
|---|---|---|
| REVEL | 0.023 | moderately benign-leaning |
| SaProt | LLR -6.25 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | — | not looked up on this page · why |
| Constraint at this position | ||
| Conservation | phyloP -1.1 | |
| Regional constraint | o/e 0.92 | unconstrained · MANE · 15 kb · p 0.012 · regional, not allelic |
| Overall | ||
| CADD | 5.008 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| South Asiangrpmax | 0.00988% | 10,120 |
| Remaining individualsnot grpmax-eligible | 0.0064% | 15,621 |
| East Asian | 0.00446% | 22,442 |
| Admixed American | 0.00333% | 29,994 |
| European (non-Finnish) | 0.00195% | 51,306 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- E2F8
- Protein
- p.Arg372Gln
- Coding
- c.1115G>A
- dbSNP
- rs375962806
- Type
- single nucleotide variant
- Location
- chr11:19230786 (GRCh38)
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/e2f8-p-arg372gln (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown